Biotech · Private company
Uniquity One (UNI)
Track this companyFree. Adds Uniquity One (UNI) to your Dealase workspace and tells you when its record changes.
Clinical trials42 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- Biological: Solrikitug high dosePhase 2 · COPDClinicalTrials.gov · fetched Nov 12, 2026
- Biological: Solrikitug low dosePhase 2 · COPDClinicalTrials.gov · fetched Nov 12, 2026
- NSI-8226Phase 2 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- Solrikitug High DosePhase 2 · Eosinophilic Esophagitis (EoE)ClinicalTrials.gov · fetched Nov 12, 2026
- Solrikitug Low DosePhase 2 · Eosinophilic Esophagitis (EoE)ClinicalTrials.gov · fetched Nov 12, 2026
- Solrikitug Mid DosePhase 2 · Eosinophilic Esophagitis (EoE)ClinicalTrials.gov · fetched Nov 12, 2026
- Cohort APhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Cohort BPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Cohort CPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- Cohort DPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic EsophagitisPHASE2 · ACTIVE_NOT_RECRUITING · started Oct 16, 2024ClinicalTrials.gov NCT06598462 · fetched Nov 12, 2026
- A Study to Evaluate Solrikitug in Participants With COPD (ZION)PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 14, 2024ClinicalTrials.gov NCT06496620 · fetched Nov 12, 2026
- A Study to Evaluate Solriktug in Adult Participants With AsthmaPHASE2 · COMPLETED · started Jul 26, 2024ClinicalTrials.gov NCT06496607 · fetched Nov 12, 2026
- A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy ParticipantsPHASE1 · COMPLETED · started Apr 29, 2024ClinicalTrials.gov NCT06640920 · fetched Nov 12, 2026